Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2009 Jul 25;139(4):1033–1040. doi: 10.1016/j.jtcvs.2009.05.032

Figure 5. Localization of 5-HT1B, 5-HT2A receptors and thromboxane receptor by Immunohistochemistry and immunofluorescence, respectively.

Figure 5

A. Expression of 5-HT1B receptor is upregulated in the vascular smooth muscle cells (VSMC). B. Expression of 5-HT2A receptor is unchanged after CP-CPB. C. Expression of thromboxane receptor is unchanged between pre and post CP-CPB Magnification: immunohistochemoistry 400x, immunofluorescence 200x. (Large open arrow indicates VSMC, small black arrow indicates endothelium).